Report Description

The global clinical biomarkers market is anticipated to observe impressive growth during the forecast period, 2023-2027. The major factors include growing occurrences of infectious diseases, and various types of cancer, and extensive development in technology are propelling the growth of the market. Clinical biomarkers are widely preferred in the field of clinical medicine to provide personalized treatment choices to patients. Biomarkers are essential to the rational development of medical therapeutics and are engaged in their use in in-vitro diagnostics purposes, especially in the fields of chronic disease and nutrition. The other factors supporting the market’s growth are, rise in R&D activities, increasing demand for personalized treatment, increasing favorable government fundings, the rising healthcare burden, rise in aging population base, increasing demand for clinical biomarker products, growing number of mergers and strategic acquisitions, and rise in number of patients.

Increasing Prevalence of Infectious Diseases and Various Types of Cancer

The increasing occurrence of infectious diseases and various types of cancer, across the globe are bolstering the growth of the market. A large number of peoples are suffering from various infectious diseases and cancers due to which there is a surge in demand for clinical biomarkers products, which is facilitating the growth of the market. The utilization of clinical biomarkers helps to diagnose and monitor the disease and also helps to identify the patient at risk for a serious adverse event or to benefit from drug treatment. According to the Centers for Disease Control and Prevention (CDC), in 2018, 1.7 billion people were infected by TB bacteria, which is approximately 23% of the world’s population. TB is the leading infectious disease in the world, taking 1.5 million lives every year. Similarly, in 2021, about 235,760 lung cancer cases were registered in the U.S. Additionally, in the U.S., over 130,000 people die every year due to lung cancer.

Technological Advancements and Rise in R&D Activities

In recent years, the adoption of highly advanced technology has allowed biomarkers to couple with novel drugs for successful diagnosis and effective treatment alternatives. For instance, in 2018, Abcam Plc., a global life sciences company, launched its product FirePlex HT Immunoassay for quick detection of neurological biomarkers. Moreover, rise in research and development for improving the effectiveness of clinical biomarkers is augmenting the growth of the market. For instance, in 2022, a University of Oxford study published in the Clinical Cancer Research Journal described a new type of blood test that can be utilized to detect a range of cancers and their spread in the human body. The study was done on 300 patients, with non-specific but concerning symptoms of cancer such as weight loss and fatigue. As per the study, cancer was properly detected in 19 out of every 20 patients that used the test. Metastatic disease was identified with an accuracy of 94%.


Download Free Sample Report

Market Segmentation

The global clinical biomarkers market is segmented into product, services, technology, clinical area, application, end user, and company. Based on product, the market is divided into efficacy biomarkers, safety biomarkers, and validation biomarkers. Based on services, the market is divided into genomic biomarker service, tissue biomarker service, cell service, and proteomics service. Based on technology, the market is divided into next generation sequencing, polymerase chain reaction, immunohistochemistry, enzyme-linked immunosorbent assay, and others. Based on clinical area, the market is divided into cancer biomarker, cardiac biomarker, neurological biomarker, infectious disease biomarker, and others. Based on application, the market is divided into translational research and clinical diagnostics. Based on end user, the market is divided into biotechnology & pharmaceutical companies, diagnostic centers, academic & research institutions, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to rise in the adoption rate of novel technology in the country.

Market Players

Agilent Technologies, Inc., Illumina, Inc., F. Hoffmann-La Roche AG, QIAGEN NV, PerkinElmer, Inc, Thermo Fischer Scientific, Inc., Bio-Rad Laboratories, Inc., NeoGenomics Laboratories, Inc., Charles River Laboratories International, Inc., Quest Diagnostics, Inc., Abbott Laboratories, Inc., Enzo Biochem Inc., Myriad Genetics, Inc., CENTOGENE N.V., and bioMérieux S.A. are some of the leading companies operating in the market.

Attribute

Details

Base Year

2021

Historic Data

2017 – 2020

Estimated Year

2022

Forecast Period

2023 – 2027

Quantitative Units

Revenue in USD Million, Volume Units and CAGR for 2017-2021 and 2022-2027

Report coverage

Revenue forecast, Volume forecast company share, competitive landscape, growth factors, and trends

Segments covered

·         Product

·         Services

·         Technology

·         Clinical Area

·         Application

·         End User

·         Company

Regional scope

North America; Asia Pacific; Europe & CIS; South America; Middle East & Africa

Country scope

United States; Canada; Mexico; China; India; Japan; South Korea; Germany; France; United Kingdom; Spain; Italy; Brazil; Argentina; Colombia; South Africa; UAE; Saudi Arabia; South Africa; Australia

Key companies profiled

Agilent Technologies, Inc., Illumina, Inc., F. Hoffmann-La Roche AG, QIAGEN NV, PerkinElmer, Inc, Thermo Fischer Scientific, Inc., Bio-Rad Laboratories, Inc., NeoGenomics Laboratories, Inc., Charles River Laboratories International, Inc., Quest Diagnostics, Inc., Abbott Laboratories, Inc., Enzo Biochem Inc., Myriad Genetics, Inc., CENTOGENE N.V., and bioMérieux S.A.

Customization scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


Report Scope:

In this report, global clinical biomarkers market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

·         Clinical Biomarkers Market, By Product:

    • Efficacy Biomarkers
    • Safety Biomarkers
    • Validation Biomarkers

·         Clinical Biomarkers Market, By Services: -

o    Genomic Biomarker Service

o    Tissue Biomarker Service

o    Cell Service,

o     Proteomics Service  

·         Clinical Biomarkers Market, By Technology:

    • Next Generation Sequencing
    • Polymerase Chain Reaction, Immunohistochemistry
    • Enzyme-Linked Immunosorbent Assay
    • Others    

·         Clinical Biomarkers Market, By Clinical Area: -

o    Cancer Biomarker

o    Cardiac Biomarker

o    Neurological Biomarker

o    Infectious Disease Biomarker

o    Others

·         Clinical Biomarkers Market, By Application:

    • Translational Research
    • Clinical Diagnostics

·         Clinical Biomarkers Market, By End User: -

o    Biotechnology & Pharmaceutical Companies

o    Diagnostic Centers

o    Academic & Research Institutions

o    Others

·         Clinical Biomarkers Market, By Region:

    • North America
      • United States
      • Canada
      • Mexico
    • Asia-Pacific
      • China
      • India
      • Japan
      • Australia
      • South Korea
    • Europe & CIS
      • Germany
      • France
      • United Kingdom
      • Spain
      • Italy
    • South America
      • Brazil
      • Argentina
      • Colombia
    • Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Clinical Biomarkers Market

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
Clinical Biomarkers Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1.    Product Overview

2.    Research Methodology

3.    Executive Summary

4.    Impact of COVID-19 on Global Clinical Biomarkers Market

5.    Voice of Customer

6.    Global Clinical Biomarkers Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Product (Efficacy Biomarkers, Safety Biomarkers, Validation Biomarkers)

6.2.2.     By Services (Genomic Biomarker Service, Tissue Biomarker Service, Cell Service,

    Proteomics Service)

6.2.3.     By Technology (Next Generation Sequencing, Polymerase Chain Reaction, Immunohistochemistry, Enzyme-Linked Immunosorbent Assay, Others)

6.2.4.     By Clinical Area (Cancer Biomarker, Cardiac Biomarker, Neurological Biomarker, Infectious Disease Biomarker, Others)

6.2.5.     By Application (Translational Research v/s Clinical Diagnostics)

6.2.6.     By End User (Biotechnology & Pharmaceutical Companies, Diagnostic Centers, Academic & Research Institutions, Others)

6.2.7.     By Region

6.2.8.     By Company (2021)

6.3.  Market Map

7.    North America Clinical Biomarkers Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Product

7.2.2.     By Services

7.2.3.     By Technology

7.2.4.     By Clinical Area

7.2.5.     By Application

7.2.6.     By End User

7.2.7.     By Country

7.3.  North America: Country Analysis

7.3.1.     United States Clinical Biomarkers Market Outlook

7.3.1.1.         Market Size & Forecast

7.3.1.1.1.             By Value

7.3.1.2.         Market Share & Forecast

7.3.1.2.1.             By Product

7.3.1.2.2.             By Services

7.3.1.2.3.             By Technology

7.3.1.2.4.             By Clinical Area

7.3.1.2.5.             By Application

7.3.1.2.6.             By End User

7.3.2.     Canada Clinical Biomarkers Market Outlook

7.3.2.1.         Market Size & Forecast

7.3.2.1.1.             By Value

7.3.2.2.         Market Share & Forecast

7.3.2.2.1.             By Product

7.3.2.2.2.             By Services

7.3.2.2.3.             By Technology

7.3.2.2.4.             By Clinical Area

7.3.2.2.5.             By Application

7.3.2.2.6.             By End User

7.3.3.     Mexico Clinical Biomarkers Market Outlook

7.3.3.1.         Market Size & Forecast

7.3.3.1.1.             By Value

7.3.3.2.         Market Share & Forecast

7.3.3.2.1.             By Product

7.3.3.2.2.             By Services

7.3.3.2.3.             By Technology

7.3.3.2.4.             By Clinical Area

7.3.3.2.5.             By Application

7.3.3.2.6.             By End User

8.    Europe Clinical Biomarkers Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Product

8.2.2.     By Services

8.2.3.     By Technology

8.2.4.     By Clinical Area

8.2.5.     By Application

8.2.6.     By End User

8.2.7.     By Country

8.3.  Europe: Country Analysis

8.3.1.     France Clinical Biomarkers Market Outlook

8.3.1.1.         Market Size & Forecast

8.3.1.1.1.             By Value

8.3.1.2.         Market Share & Forecast

8.3.1.2.1.             By Product

8.3.1.2.2.             By Services

8.3.1.2.3.             By Technology

8.3.1.2.4.             By Clinical Area

8.3.1.2.5.             By Application

8.3.1.2.6.             By End User

8.3.2.     Germany Clinical Biomarkers Market Outlook

8.3.2.1.         Market Size & Forecast

8.3.2.1.1.             By Value

8.3.2.2.         Market Share & Forecast

8.3.2.2.1.             By Product

8.3.2.2.2.             By Services

8.3.2.2.3.             By Technology

8.3.2.2.4.             By Clinical Area

8.3.2.2.5.             By Application

8.3.2.2.6.             By End User

8.3.3.     United Kingdom Clinical Biomarkers Market Outlook

8.3.3.1.         Market Size & Forecast

8.3.3.1.1.             By Value

8.3.3.2.         Market Share & Forecast

8.3.3.2.1.             By Product

8.3.3.2.2.             By Services

8.3.3.2.3.             By Technology

8.3.3.2.4.             By Clinical Area

8.3.3.2.5.             By Application

8.3.3.2.6.             By End User

8.3.4.     Italy Clinical Biomarkers Market Outlook

8.3.4.1.         Market Size & Forecast

8.3.4.1.1.             By Value

8.3.4.2.         Market Share & Forecast

8.3.4.2.1.             By Product

8.3.4.2.2.             By Services

8.3.4.2.3.             By Technology

8.3.4.2.4.             By Clinical Area

8.3.4.2.5.             By Application

8.3.4.2.6.             By End User

8.3.5.     Spain Clinical Biomarkers Market Outlook

8.3.5.1.         Market Size & Forecast

8.3.5.1.1.             By Value

8.3.5.2.         Market Share & Forecast

8.3.5.2.1.             By Product

8.3.5.2.2.             By Services

8.3.5.2.3.             By Technology

8.3.5.2.4.             By Clinical Area

8.3.5.2.5.             By Application

8.3.5.2.6.             By End User

9.    Asia-Pacific Clinical Biomarkers Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Product

9.2.2.     By Services

9.2.3.     By Technology

9.2.4.     By Clinical Area

9.2.5.     By Application

9.2.6.     By End User

9.2.7.     By Country

9.3.  Asia-Pacific: Country Analysis

9.3.1.     China Clinical Biomarkers Market Outlook

9.3.1.1.         Market Size & Forecast

9.3.1.1.1.             By Value

9.3.1.2.         Market Share & Forecast

9.3.1.2.1.             By Product

9.3.1.2.2.             By Services

9.3.1.2.3.             By Technology

9.3.1.2.4.             By Clinical Area

9.3.1.2.5.             By Application

9.3.1.2.6.             By End User

9.3.2.     India Clinical Biomarkers Market Outlook

9.3.2.1.         Market Size & Forecast

9.3.2.1.1.             By Value

9.3.2.2.         Market Share & Forecast

9.3.2.2.1.             By Product

9.3.2.2.2.             By Services

9.3.2.2.3.             By Technology

9.3.2.2.4.             By Clinical Area

9.3.2.2.5.             By Application

9.3.2.2.6.             By End User

9.3.3.     Japan Clinical Biomarkers Market Outlook

9.3.3.1.         Market Size & Forecast

9.3.3.1.1.             By Value

9.3.3.2.         Market Share & Forecast

9.3.3.2.1.             By Product

9.3.3.2.2.             By Services

9.3.3.2.3.             By Technology

9.3.3.2.4.             By Clinical Area

9.3.3.2.5.             By Application

9.3.3.2.6.             By End User

9.3.4.     South Korea Clinical Biomarkers Market Outlook

9.3.4.1.         Market Size & Forecast

9.3.4.1.1.             By Value

9.3.4.2.         Market Share & Forecast

9.3.4.2.1.             By Product

9.3.4.2.2.             By Services

9.3.4.2.3.             By Technology

9.3.4.2.4.             By Clinical Area

9.3.4.2.5.             By Application

9.3.4.2.6.             By End User

9.3.5.     Australia Clinical Biomarkers Market Outlook

9.3.5.1.         Market Size & Forecast

9.3.5.1.1.             By Value

9.3.5.2.         Market Share & Forecast

9.3.5.2.1.             By Product

9.3.5.2.2.             By Services

9.3.5.2.3.             By Technology

9.3.5.2.4.             By Clinical Area

9.3.5.2.5.             By Application

9.3.5.2.6.             By End User

10.  South America Clinical Biomarkers Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Product

10.2.2.  By Services

10.2.3.  By Technology

10.2.4.  By Clinical Area

10.2.5.  By Application

10.2.6.  By End User

10.2.7.  By Country

10.3.              South America: Country Analysis

10.3.1.  Brazil Clinical Biomarkers Market Outlook

10.3.1.1.      Market Size & Forecast

10.3.1.1.1.           By Value

10.3.1.2.      Market Share & Forecast

10.3.1.2.1.           By Product

10.3.1.2.2.           By Services

10.3.1.2.3.           By Technology

10.3.1.2.4.           By Clinical Area

10.3.1.2.5.           By Application

10.3.1.2.6.           By End User

10.3.2.  Argentina Clinical Biomarkers Market Outlook

10.3.2.1.      Market Size & Forecast

10.3.2.1.1.           By Value

10.3.2.2.      Market Share & Forecast

10.3.2.2.1.           By Product

10.3.2.2.2.           By Services

10.3.2.2.3.           By Technology

10.3.2.2.4.           By Clinical Area

10.3.2.2.5.           By Application

10.3.2.2.6.           By End User

10.3.3.  Colombia Clinical Biomarkers Market Outlook

10.3.3.1.      Market Size & Forecast

10.3.3.1.1.           By Value

10.3.3.2.      Market Share & Forecast

10.3.3.2.1.           By Product

10.3.3.2.2.           By Services

10.3.3.2.3.           By Technology

10.3.3.2.4.           By Clinical Area

10.3.3.2.5.           By Application

10.3.3.2.6.           By End User

11.  Middle East and Africa Clinical Biomarkers Market Outlook

11.1.              Market Size & Forecast

11.1.1.  By Value

11.2.              Market Share & Forecast

11.2.1.  By Product

11.2.2.  By Services

11.2.3.  By Technology

11.2.4.  By Clinical Area

11.2.5.  By Application

11.2.6.  By End User

11.2.7.  By Country

11.3.              MEA: Country Analysis

11.3.1.  South Africa Clinical Biomarkers Market Outlook

11.3.1.1.      Market Size & Forecast

11.3.1.1.1.           By Value

11.3.1.2.      Market Share & Forecast

11.3.1.2.1.           By Product

11.3.1.2.2.           By Services

11.3.1.2.3.           By Technology

11.3.1.2.4.           By Clinical Area

11.3.1.2.5.           By Application

11.3.1.2.6.           By End User

11.3.2.  Saudi Arabia Clinical Biomarkers Market Outlook

11.3.2.1.      Market Size & Forecast

11.3.2.1.1.           By Value

11.3.2.2.      Market Share & Forecast

11.3.2.2.1.           By Product

11.3.2.2.2.           By Services

11.3.2.2.3.           By Technology

11.3.2.2.4.           By Clinical Area

11.3.2.2.5.           By Application

11.3.2.2.6.           By End User

11.3.3.  UAE Clinical Biomarkers Market Outlook

11.3.3.1.      Market Size & Forecast

11.3.3.1.1.           By Value

11.3.3.2.      Market Share & Forecast

11.3.3.2.1.           By Product

11.3.3.2.2.           By Services

11.3.3.2.3.           By Technology

11.3.3.2.4.           By Clinical Area

11.3.3.2.5.           By Application

11.3.3.2.6.           By End User

12.  Market Dynamics

12.1.              Drivers

12.2.              Challenges

13.  Market Trends & Developments

14.  Competitive Landscape (Inclusive of SWOT Analysis)

14.1.              Agilent Technologies, Inc.

14.2.              Illumina, Inc.

14.3.              F. Hoffmann-La Roche AG

14.4.              QIAGEN NV

14.5.              PerkinElmer, Inc

14.6.              Thermo Fischer Scientific, Inc.

14.7.              Bio-Rad Laboratories, Inc.

14.8.              NeoGenomics Laboratories, Inc.

14.9.              Charles River Laboratories International, Inc.

14.10.            Quest Diagnostics, Inc.

14.11.            Abbott Laboratories, Inc.

14.12.            Enzo Biochem Inc.

14.13.            Myriad Genetics, Inc.

14.14.            CENTOGENE N.V.

14.15.            bioMérieux S.A.

15.  Strategic Recommendations

Figures and Tables

Frequently asked questions

down-arrow

Growing incidence of infectious diseases, and various types of cancer, and rising technological advancements are driving the demand for the global clinical biomarkers market.

down-arrow

Agilent Technologies, Inc., Illumina, Inc., F. Hoffmann-La Roche AG, QIAGEN NV, PerkinElmer, Inc, Thermo Fischer Scientific, Inc., Bio-Rad Laboratories, Inc., NeoGenomics Laboratories, Inc., Charles River Laboratories International, Inc., Quest Diagnostics, Inc., Abbott Laboratories, Inc., Enzo Biochem Inc., Myriad Genetics, Inc., CENTOGENE N.V., and bioMérieux S.A. are the key players operating in the global clinical biomarkers market.

down-arrow

The higher cost of product/service hindering the development in low-income countries, complex regulatory frameworks delaying the approval of new clinical biomarkers tests and lack of skilled professionals may hamper the growth of the global clinical biomarkers market.

down-arrow

The healthcare sector is the key user of clinical biomarkers.

profile

Sakshi Bajaal

Business Consultant
Press Release

Clinical Biomarkers Market to be dominated by Growing Occurrences of Cancer through 2027

Oct, 2022

Growing occurrences of infectious diseases and various types of cancers to drive the clinical biomarkers market in the forecast period, 2023-2027.